Andrew Lee is a seasoned professional in health economics and outcomes research, currently serving as Senior Director of Global Health Economics and Outcomes Research at BridgeBio since October 2025. Prior to this role, Andrew held significant positions including Executive Director of Early Development HEOR Strategy at Sage Therapeutics and Senior Director for HEOR Pipeline Programs at Vertex Pharmaceuticals. Andrew's extensive experience also includes leadership roles at Sunovion Pharmaceuticals, Biogen, Sanofi, and Amgen, focusing on various therapeutic areas such as neurology and oncology. Andrew's academic credentials feature a PhD in Health Care Management & Economics from The Wharton School and a ScM in Health and Social Behavior from Harvard T.H. Chan School of Public Health, complemented by a BA in History and Philosophy of Science and Medicine from the University of Chicago.
This person is not in any teams
This person is not in any offices